CARDIOVASCULAR SYSTEMS INC. EX1000 Manual De Usuario
9
2.6. VIPERWIRE ADVANCE Peripheral Guide Wire Package Contents
The guide wire and guide wire torquer are packaged separately from the OAD, are
supplied sterile and are for single-use only. Each VIPERWIRE ADVANCE package
contains:
supplied sterile and are for single-use only. Each VIPERWIRE ADVANCE package
contains:
• Five (5) guide wires
• Five (5) torquers
• Five (5) torquers
2.7. Lubricant Description
VIPERSLIDE Lubricant reduces friction between the OAD drive shaft and the guide wire.
It is packaged separately from the OAD.
It is packaged separately from the OAD.
Note: Please refer to the VIPERSLIDE Lubricant IFU prior to starting the atherectomy
procedure.
procedure.
3. Indications for Use
The DIAMONDBACK 360 Peripheral Orbital Atherectomy System Exchangeable Series is a
percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive
atherosclerotic disease in peripheral arteries and who are acceptable candidates for
percutaneous transluminal atherectomy.
percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive
atherosclerotic disease in peripheral arteries and who are acceptable candidates for
percutaneous transluminal atherectomy.
The OAS supports removal of stenotic material from artificial arteriovenous dialysis fistulae (AV
shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in
patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous
transluminal angioplasty.
shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in
patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous
transluminal angioplasty.
4. Contraindications
Use of the OAS is contraindicated in the following situations:
• The guide wire cannot be passed across the peripheral lesion.
• The system cannot be used in coronary arteries.
• The target lesion is within a bypass graft or stent.
• The patient has angiographic evidence of thrombus; thrombolytic therapy must be
instituted prior to atherectomy.
• The patient has angiographic evidence of significant dissection at the treatment site. The
patient may be treated conservatively to permit the dissection to heal before treating the
lesion with the OAS.
lesion with the OAS.